ArticleTherapeutic advances in gastroenterology2026
The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomes.
Keith Bodger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.